mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis

Detalles Bibliográficos
Autores principales: Rama, Tiago Azenha, Moreira, André, Castells, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816615/
https://www.ncbi.nlm.nih.gov/pubmed/33485650
http://dx.doi.org/10.1016/j.jaci.2021.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816615/
https://www.ncbi.nlm.nih.gov/pubmed/33485650
http://dx.doi.org/10.1016/j.jaci.2021.01.004

Ejemplares similares